Skip to main content

Sigilon Therapeutics, Inc.

SGTXDelisted Aug 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001821323

Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Sigilon Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−2 vs. Q4 2021
Shares held
18.2M
−673.8K (−3.6%) vs. Q4 2021
Total value
$26.8M
−$25.4M (−48.6%) vs. Q4 2021
New holders
5
8 more added
Sold out
7
21 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 48 institutions
Q1 2021: 52 institutionsQ2 2021: 52 institutionsQ3 2021: 45 institutionsQ4 2021: 50 institutionsQ1 2022: 48 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 32 institutionsQ1 2023: 32 institutionsQ2 2023: 16 institutionsQ3 2023: 1 institutionQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $26.8M
Q1 2021: $438.5MQ2 2021: $209.2MQ3 2021: $109.0MQ4 2021: $52.2MQ1 2022: $26.8MQ2 2022: $14.2MQ3 2022: $8.50MQ4 2022: $6.12MQ1 2023: $16.5MQ2 2023: $26.6MQ3 2023: $4.49KQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SGTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20231$4.49K
Q2 202316$26.6M
Q1 202332$16.5M
Q4 202232$6.12M
Q3 202233$8.50M
Q2 202237$14.2M
Q1 202248$26.8M
Q4 202150$52.2M
Q3 202145$109.0M
Q2 202152$209.2M
Q1 202152$438.5M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Sigilon Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding SGTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Flagship Pioneering Inc.10,370,369$15.2M0.36%00.0%Unchanged
BlackRock Inc.1,713,759$2.52M0.00%−22,798−1.3%Reduced
Canada Pension Plan Investment Board1,485,185$2.18M0.00%00.0%Unchanged
FMR LLC1,067,327$1.57M0.00%−1,373−0.1%Reduced
HarbourVest Partners LLC740,740$1.09M0.22%00.0%Unchanged
State of Wisconsin Investment Board509,629$749.0K0.00%00.0%Unchanged
State Street Corp330,471$486.0K0.00%+69,662+26.7%Added
Vanguard Group Inc310,502$456.0K0.00%−219,057−41.4%Reduced
Artal Group S.A.276,000$406.0K0.02%00.0%Unchanged
Renaissance Technologies LLC275,600$405.0K0.00%+156,689+131.8%Added
Geode Capital Management, LLC247,177$363.0K0.00%+13,024+5.6%Added
Bridgeway Capital Management, LLC200,000$294.0K0.01%00.0%Unchanged
Northern Trust Corp117,249$172.0K0.00%−5,740−4.7%Reduced
JPMorgan Chase & Co100,780$148.0K0.00%−5,747−5.4%Reduced
Choate Investment Advisors66,666$98.0K0.01%00.0%Unchanged
Morgan Stanley55,964$82.0K0.00%−340,033−85.9%Reduced
Bank of New York Mellon Corp44,366$66.0K0.00%−7,250−14.0%Reduced
D. E. Shaw & Co., Inc.41,455$61.0K0.00%−4,787−10.4%Reduced
Charles Schwab Investment Management Inc31,572$47.0K0.00%−8,164−20.5%Reduced
Soundmark Wealth Management, LLC25,555$38.0K0.03%00.0%Unchanged
Nuveen Asset Management, LLC22,624$31.0K0.00%00.0%Unchanged
Bank of America Corp19,440$29.0K0.00%−6,850−26.1%Reduced
Royal Bank of Canada19,634$28.0K0.00%−1,903−8.8%Reduced
Susquehanna International Group, LLP18,063$27.0K0.00%−25,054−58.1%Reduced
Deutsche Bank AG17,317$25.0K0.00%+8,079+87.5%Added
Two Sigma Investments, LP15,559$23.0K0.00%−16,496−51.5%Reduced
Goldman Sachs Group Inc15,157$22.0K0.00%−40,369−72.7%Reduced
Rhumbline Advisers11,206$16.0K0.00%+276+2.5%Added
Cambridge Investment Research Advisors, Inc.10,991$16.0K0.00%+10,991New
Tower Research Capital LLC (TRC)9,371$14.0K0.00%+5,663+152.7%Added
Wells Fargo & Company8,975$13.0K0.00%−5,326−37.2%Reduced
American International Group, Inc.7,548$11.0K0.00%−531−6.6%Reduced
California State Teachers Retirement System6,753$10.0K0.00%−1,548−18.6%Reduced
New York State Common Retirement Fund6,800$10.0K0.00%−123−1.8%Reduced
Allspring Global Investments Holdings, LLC5,807$8.00K0.00%−1,051−15.3%Reduced
Barclays PLC5,074$8.00K0.00%+5,074New
Captrust Financial Advisors5,000$7.00K0.00%+5,000New
Federated Hermes, Inc.3,793$6.00K0.00%+1,923+102.8%Added
UBS Group AG2,568$4.00K0.00%−3,963−60.7%Reduced
Rockefeller Capital Management L.P.2,950$4.00K0.00%00.0%Unchanged
Amalgamated Bank1,955$3.00K0.00%+1,955New
Amalgamated Financial Corp.1,955$3.00K0.00%+1,955New
Citigroup Inc1,222$2.00K0.00%−2,671−68.6%Reduced
Legal & General Group Plc1,231$2.00K0.00%00.0%Unchanged
Simplex Trading, LLC1,853$2.00K0.00%+1,299+234.5%Added
Ameritas Investment Partners, Inc.628$1.00K0.00%00.0%Unchanged
Toronto Dominion Bank9$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.100$00.00%00.0%Unchanged
Jacobs Levy Equity Management, Inc0$00.00%−142,781−100.0%Sold out
Millennium Management LLC0$00.00%−37,285−100.0%Sold out
Nomura Holdings Inc0$00.00%−28,688−100.0%Sold out
Acadian Asset Management LLC0$00.00%−11,100−100.0%Sold out
Citadel Advisors LLC0$00.00%−10,896−100.0%Sold out
Marshall Wace, LLP0$00.00%−3,771−100.0%Sold out
Shore Point Advisors, LLC0$00.00%−20−100.0%Sold out